id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0014-0007,FDA,FDA-2011-E-0014,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2024-03-13T12:03:47Z,,0,0,090000648119c23f
FDA-2011-E-0014-0006,FDA,FDA-2011-E-0014,Regulatory Review Period for Purposes of Patent Extension: PROLIA,Notice,General Notice,2012-05-07T04:00:00Z,2012,5,2012-05-07T04:00:00Z,2012-07-07T03:59:59Z,2012-05-07T14:30:41Z,2012-10959,0,0,0900006481006569
FDA-2011-E-0014-0005,FDA,FDA-2011-E-0014,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2012-04-18T04:00:00Z,2012,4,2012-04-18T04:00:00Z,,2024-03-13T12:03:22Z,,0,0,0900006480ff39ad
FDA-2011-E-0014-0004,FDA,FDA-2011-E-0014,U.S. Patent & Trademark Office to FDA/CDER  - Letter,Other,Letter(s),2012-01-10T05:00:00Z,2012,1,2012-01-10T05:00:00Z,,2012-01-10T17:33:32Z,,0,0,0900006480f91faf